CO5160255A1 - DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN - Google Patents
DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDENInfo
- Publication number
- CO5160255A1 CO5160255A1 CO00003864A CO00003864A CO5160255A1 CO 5160255 A1 CO5160255 A1 CO 5160255A1 CO 00003864 A CO00003864 A CO 00003864A CO 00003864 A CO00003864 A CO 00003864A CO 5160255 A1 CO5160255 A1 CO 5160255A1
- Authority
- CO
- Colombia
- Prior art keywords
- piridazino
- dihidro
- indol
- carboxamide
- oxo
- Prior art date
Links
- CQILOHWHIWNQOE-UHFFFAOYSA-N indole-1-carboxamide Chemical compound C1=CC=C2N(C(=O)N)C=CC2=C1 CQILOHWHIWNQOE-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9900805A FR2788776B1 (fr) | 1999-01-26 | 1999-01-26 | Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5160255A1 true CO5160255A1 (es) | 2002-05-30 |
Family
ID=9541211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00003864A CO5160255A1 (es) | 1999-01-26 | 2000-01-25 | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6451795B1 (enExample) |
| EP (1) | EP1149101B1 (enExample) |
| JP (1) | JP4574860B2 (enExample) |
| AR (1) | AR030016A1 (enExample) |
| AT (1) | ATE236905T1 (enExample) |
| AU (1) | AU3057800A (enExample) |
| CO (1) | CO5160255A1 (enExample) |
| DE (1) | DE60002043T2 (enExample) |
| ES (1) | ES2194696T3 (enExample) |
| FR (1) | FR2788776B1 (enExample) |
| WO (1) | WO2000044751A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2788696B1 (fr) * | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
| FR2811990A1 (fr) * | 2000-07-24 | 2002-01-25 | Sanofi Synthelabo | DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| FR2833953B1 (fr) * | 2001-12-21 | 2004-12-03 | Sanofi Synthelabo | DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| FR2838124B1 (fr) * | 2002-04-03 | 2004-05-28 | Sanofi Synthelabo | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique |
| GB0523506D0 (en) * | 2005-11-18 | 2005-12-28 | Hammersmith Imanet Ltd | Novel in vivo imaging compounds |
| GB0818738D0 (en) * | 2008-10-13 | 2008-11-19 | Ge Healthcare Ltd | Imaging neuroflammation |
| GB0905328D0 (en) * | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
| BR112012021579A2 (pt) * | 2010-03-26 | 2019-09-24 | Ge Healthcare Ltd | traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição. |
| US9220795B2 (en) | 2011-09-22 | 2015-12-29 | Ge Healthcare Limited | Indole derivatives |
| GB201312768D0 (en) * | 2013-07-17 | 2013-08-28 | Ge Healthcare Ltd | Work-up procedure |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9109972D0 (en) * | 1991-05-09 | 1991-07-03 | Ici Plc | Therapeutic compounds |
| GB9411955D0 (en) * | 1994-06-15 | 1994-08-03 | Merck Sharp & Dohme | Therapeutic agents |
| FR2754262B1 (fr) * | 1996-10-08 | 1998-10-30 | Synthelabo | Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique |
| FR2766823B1 (fr) | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
-
1999
- 1999-01-26 FR FR9900805A patent/FR2788776B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-21 EP EP00900636A patent/EP1149101B1/fr not_active Expired - Lifetime
- 2000-01-21 JP JP2000596007A patent/JP4574860B2/ja not_active Expired - Fee Related
- 2000-01-21 US US09/889,984 patent/US6451795B1/en not_active Expired - Fee Related
- 2000-01-21 AT AT00900636T patent/ATE236905T1/de active
- 2000-01-21 ES ES00900636T patent/ES2194696T3/es not_active Expired - Lifetime
- 2000-01-21 AU AU30578/00A patent/AU3057800A/en not_active Abandoned
- 2000-01-21 WO PCT/FR2000/000134 patent/WO2000044751A1/fr not_active Ceased
- 2000-01-21 DE DE60002043T patent/DE60002043T2/de not_active Expired - Lifetime
- 2000-01-25 AR ARP000100304A patent/AR030016A1/es unknown
- 2000-01-25 CO CO00003864A patent/CO5160255A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1149101B1 (fr) | 2003-04-09 |
| AU3057800A (en) | 2000-08-18 |
| FR2788776A1 (fr) | 2000-07-28 |
| EP1149101A1 (fr) | 2001-10-31 |
| DE60002043D1 (de) | 2003-05-15 |
| JP2002535406A (ja) | 2002-10-22 |
| WO2000044751A1 (fr) | 2000-08-03 |
| AR030016A1 (es) | 2003-08-13 |
| JP4574860B2 (ja) | 2010-11-04 |
| ES2194696T3 (es) | 2003-12-01 |
| DE60002043T2 (de) | 2004-02-19 |
| US6451795B1 (en) | 2002-09-17 |
| FR2788776B1 (fr) | 2001-02-23 |
| ATE236905T1 (de) | 2003-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5640136A2 (es) | Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen | |
| CO5310534A1 (es) | Nuevos derivados de androstano anti-inflamatorios | |
| CO5570660A2 (es) | Indazolilpirrolotriazinas c-6 modificadas | |
| CO5601018A2 (es) | Derivados de n-fenil-2-pirimidin-amina | |
| AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
| ECSP045369A (es) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
| SV1998000008A (es) | Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114 | |
| PA8621501A1 (es) | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la síntesis de los mismos | |
| CO5320599A1 (es) | Inhibidores no peptidilicos de la union a las celulas depen dientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| BR0316609A (pt) | Sinomenina e compostos de sinomenina, sìntese e uso | |
| HUP9901590A2 (hu) | Szubsztituált aza- és diaza-cikloheptán- és -ciklooktán-származékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
| AR006890A1 (es) | Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticos | |
| CO5210883A1 (es) | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO [4,5,-b]INDOL- 1-ACETAMIDA | |
| CO5160255A1 (es) | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN | |
| CO4900066A1 (es) | Derivados de tetrahidroquinolina | |
| CO5160242A1 (es) | UTILIZACION DE DERIVADOS DE PIRIDAZINO [4,5-b] INDOL-1- ACETAMIDA, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL | |
| CO5380019A1 (es) | Azalidas de 13 miembros utiles como agentes antibioticos | |
| AR051467A1 (es) | Derivados de aminopiridina con accion inhibitoria selectiva de la aurora quinasa a | |
| CO5040004A1 (es) | 2-4-diamino-1,3,5-triazinas, su preparacion y empleo como herbicidas y fitorreguladores | |
| CO5130006A1 (es) | Compuestos de pirazina | |
| CO5150179A1 (es) | Derivados de n-etilpirimidin o (piridin)-2-(1,2-benzoisoxa- zol-3-il)-octahidro-2h-pirido[1,2-a]pirazina y sus composiciones farmaceuticas | |
| BR0213731A (pt) | Compostos de silìcio | |
| HUP9801386A2 (hu) | Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
| CO5251439A1 (es) | Compuestos calciliticos | |
| CO5080785A1 (es) | Derivados heterociclicos |